GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine
GlaxoSmithKline is in the running to bring a new Covid-19 vaccine on to the market by the year end, thanks to positive results from early trials that will allow the formula to enter into late-stage studies within weeks. The news will offer some relief for GSK as it plays catchup with rivals, and to its …
GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine Read More »